Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Atco Pharma International products and prices in Pakistan

Importer / marketer Its products are registered under a DRAP Drug Sale Licence (DSL), typically imported finished products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical company / importer · Karachi · Pakistan

Karachi pharmaceutical entity represented in DRAP PharmaPrice as a licensed source for oncology, vaccine and other imported or marketed pharmaceutical products.

Atco Pharma International products in Pakistan

Atco Pharma International (Pvt) Ltd has 38 medicine presentations registered in Pakistan under 21 brands, covering 18 generic medicines. Most of its products are in Oncology & immunology, Respiratory & allergy and Vaccines & immunologicals. Its brands with the most registered strengths and packs are Daxotel (Docetaxel), FIVOFLU (Fluorouracil (5-FU)), Nanoxel (Paclitaxel) and AgB (Hepatitis B vaccine (recombinant HBsAg), HbsAg SURFACE ANTIGEN). 38 products have an official DRAP price on MedInfoBase. See all 21 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation12 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check11 Oct 2026Latest source-check date across this published portfolio
Latest effective price date16 Sep 2026Newest effective date among published current price records
Corporate profile evidence1 sourceCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Atco Pharma International (Pvt.) Ltd.
Company type
Private pharmaceutical company / importer
Address
B-18, S.I.T.E., Karachi, Pakistan
Phone
+92 21 111111645
Corporate source details checked
16 Aug 2026
Corporate profile completeness
63%
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DSL 046 38 linked products · source seen 12 Nov 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx38public portfolio records represented
REG30unique registrations represented
IDX38indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER14registry-verified exact registrations
PKR38current validated price records
G18generic molecules in indexed catalogue
DF5dosage-form groups
TA6therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage100%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage97%
priced packs safely normalized per unit
Comparable-market coverage26%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixAtco Pharma International (Pvt) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/atco-pharma-international-pvt-ltdGenerated 12 Nov 2026Oncology & immunology25 · 66%Respiratory & allergy6 · 16%Vaccines & immunologicals2 · 5%Reproductive & genitourinary2 · 5%Gastrointestinal & hepatology2 · 5%Hematology & thrombosis1 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioAtco Pharma International (Pvt) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/atco-pharma-international-pvt-ltdGenerated 12 Nov 202638presentationsInjection25 · 66%Inhalation6 · 16%Infusion3 · 8%Sachet2 · 5%Vaccine2 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionAtco Pharma International (Pvt) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/atco-pharma-international-pvt-ltdGenerated 12 Nov 202610comparable productsBelow peer median4 · 40%Near peer median2 · 20%Above peer median4 · 40%Company median price position-0.4%Lowest-price equivalents3Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsAtco Pharma International (Pvt) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/atco-pharma-international-pvt-ltdGenerated 12 Nov 2026AJM Pharma (Pvt.) Limited10 shared56% overlapPharmasol (Pvt) Ltd.8 shared44% overlapCCL Pharmaceuticals (Pvt.) Limited8 shared44% overlapPharmedic Laboratories (Pvt.) Ltd L…8 shared44% overlapHelix Pharma (Pvt)., Ltd.7 shared39% overlapPfizer Pakistan Limited7 shared39% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Oncology & immunology25 products · 66%
Respiratory & allergy6 products · 16%
Vaccines & immunologicals2 products · 5%
Reproductive & genitourinary2 products · 5%
Gastrointestinal & hepatology2 products · 5%
Hematology & thrombosis1 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antineoplastic medicines23 products · 61%
Inhaled controller therapy6 products · 16%
Vaccines2 products · 5%
Uterotonics / obstetric medicines2 products · 5%
Inflammatory bowel disease medicines2 products · 5%
Antimetabolite / immunomodulator2 products · 5%
Granulocyte colony-stimulating factors1 products · 3%
Formulation footprint

Dosage forms

Injection25 products
Inhalation6 products
Infusion3 products
Sachet2 products
Vaccine2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 DaxotelDocetaxel 4presentations 120 mg/6 mL, 160 mg/8 mL, 20 mg/mL, 80 mg/4 mL · Injection, Infusion #2 FIVOFLUFluorouracil (5-FU) 4presentations 250 mg/5 mL (50 mg/mL), 50 mg/mL, 500 mg (50 mg/mL) · Injection #3 NanoxelPaclitaxel 3presentations 100 mg, 30 mg, 300 mg · Injection #4 GemitaGemcitabine 2presentations 1 g, 200 mg · Injection #5 KemocarbCarboplatin 2presentations 150 mg/15 mL, 450 mg/45 mL · Injection #6 KEMOPLATCisplatin 2presentations 10 mg/20 mL, 50 mg/100 mL · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Atco Pharma International (Pvt) Ltd is priced against the market

10 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

AJM Pharma (Pvt.) Limited124 products · 61 generics 10shared generics Pharmasol (Pvt) Ltd.252 products · 102 generics 8shared generics CCL Pharmaceuticals (Pvt.) Limited250 products · 98 generics 8shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers30Distinct registrations among indexed, published, presentation-validated products only
Verified price observations38
Products with a verified price38
Products with multiple price observations0
Source records with multiple versions37
Latest portfolio source check11 Oct 2026
Latest effective price date16 Sep 2026
Latest source observation12 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

30 unique registration(s) · 38 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Adrim Doxorubicin 50 mg/25 mL Injection 1 vial 044869 PKR 3,485.93 PKR 3,485.93/vial/unit 🔒 Pharma Pro
AgB HbsAg SURFACE ANTIGEN 20 mcg Vaccine 1vial 041166 PKR 457.51 PKR 457.51/vial/unit No comparator
AgB Hepatitis B vaccine (recombinant HBsAg) 10 mcg/0.5 mL Vaccine injection 1 vial 041167 PKR 281.55 PKR 281.55/vial/unit No comparator
Bortezomib Bortezomib 3.5 mg Injection 1 vial 135882 PKR 28,175.00 PKR 28,175.00/vial/unit 🔒 Pharma Pro
Daxotel Docetaxel 80 mg/4 mL Injection 4ml x 1's 090528 PKR 31,598.91 PKR 7,899.73/mL No comparator
Daxotel Docetaxel 160 mg/8 mL Injection 8ml x 1's 090529 PKR 64,716.02 PKR 8,089.50/mL No comparator
Daxotel Docetaxel 120 mg/6 mL Injection 6ml x 1's 090530 PKR 51,773.98 PKR 8,629.00/mL No comparator
Daxotel Docetaxel 20 mg/mL Concentrate for solution for infusion 1's 110514 PKR 12,826.25 PKR 12,826.25/vial/unit 🔒 Pharma Pro
FIVOFLU Fluorouracil (5-FU) 500 mg (50 mg/mL) Injection 1's 045755 PKR 147.73 PKR 147.73/vial/unit No comparator
FIVOFLU Fluorouracil (5-FU) 50 mg/mL Injection 5's 045755 PKR 738.63 PKR 147.73/vial/unit No comparator
FIVOFLU Fluorouracil (5-FU) 250 mg/5 mL (50 mg/mL) Injection 1's 045756 PKR 92.33 PKR 92.33/vial/unit No comparator
FIVOFLU Fluorouracil (5-FU) 50 mg/mL Injection 5's 045756 PKR 461.65 PKR 92.33/vial/unit No comparator
FYTOSID Etoposide 100 mg Injection vial 044868 PKR 1,459.23 PKR 1,459.23/vial/unit 🔒 Pharma Pro
Gemita Gemcitabine 200 mg Lyophilized powder for injection 1 vial 053859 PKR 3,410.60 PKR 3,410.60/vial/unit 🔒 Pharma Pro
Gemita Gemcitabine 1 g Lyophilized powder for injection 1 vial 053860 PKR 16,961.44 PKR 16,961.44/vial/unit 🔒 Pharma Pro
Kemocarb Carboplatin 150 mg/15 mL Injection 15 ml vial 045753 PKR 4,530.51 PKR 302.03/mL 🔒 Pharma Pro
Kemocarb Carboplatin 450 mg/45 mL Injection 45 ml vial 045754 PKR 12,851.61 PKR 285.59/mL No comparator
KEMOPLAT Cisplatin 10 mg/20 mL Injection 20 ml vial 045748 PKR 784.80 PKR 39.24/mL No comparator
KEMOPLAT Cisplatin 50 mg/100 mL Injection 100ml vial 045749 PKR 2,539.06 PKR 25.39/mL No comparator
Nanoxel Paclitaxel 30 mg Injection 1 vial 052262 PKR 6,122.40 PKR 6,122.40/vial/unit 🔒 Pharma Pro
Nanoxel Paclitaxel 100 mg Injection 1 vial 052264 PKR 25,239.01 PKR 25,239.01/vial/unit 🔒 Pharma Pro
Nanoxel Paclitaxel 300 mg Injection 1 vial 052266 PKR 57,214.91 PKR 57,214.91/vial/unit 🔒 Pharma Pro
NEUMOCORT Budesonide 200 mcg Metered-dose inhaler 150 doses 059036 PKR 293.61 PKR 1.96/dose No comparator
NEUMOCORT FORTE Budesonide 400 mcg Metered-dose inhaler 150 doses 059037 PKR 466.31 PKR 3.11/dose No comparator
NEUMOCORT FORTE METERD-DOSE INHALER Budesonide 400 mcg Metered-dose inhaler 200 doses 059037 PKR 621.16 PKR 3.11/dose No comparator
NEUMOCORT FORTE METERD-DOSE INHALER Budesonide 400 mcg Metered-dose inhaler 100 doses 059037 PKR 311.46 PKR 3.11/dose No comparator
NEUMOCORT METERD-DOSE INHALER Budesonide 200 mcg Metered-dose inhaler 200 doses 059036 PKR 391.48 PKR 1.96/dose No comparator
NEUMOCORT METERD-DOSE INHALER Budesonide 200 mcg Metered-dose inhaler 100 doses 059036 PKR 195.73 PKR 1.96/dose No comparator
Neutrofil Filgrastim 48 MU/1.6 mL Injection 1 Vial 044837 PKR 8,863.60 PKR 8,863.60/vial/unit No comparator
Oxitan Oxaliplatin 50 mg/10 mL (5 mg/mL) Solution for infusion 1 Vial 110554 PKR 14,126.70 PKR 14,126.70/vial/unit No comparator
Oxitan Oxaliplatin 100 mg/20 mL (5 mg/mL) Solution for infusion 1 Vial 110555 PKR 28,253.39 PKR 28,253.39/vial/unit No comparator
PABAL RTS Carbetocin 100 mcg/mL Solution for IV/IM injection 1's 115734 PKR 409.28 PKR 409.28/vial/unit No comparator
PABAL® RTS 100 MICROGRAMS Carbetocin 100 MCG/mL Injection 5's 115734 PKR 1,964.53 PKR 392.91/vial/unit No comparator
PENTASA MESALAZINE 1 g Sachet 50's 043091 PKR 4,654.11 PKR 93.08/sachet No comparator
PENTASA MESALAZINE 1 g Sachet 7-Bottles 044836 PKR 4,044.02 — No comparator
VINELBINE Vinorelbine tartrate 10 mg Injection 1ml vial 045751 PKR 3,807.68 PKR 3,807.68/mL No comparator
Zexate Methotrexate 50 mg (25 mg/mL) Injection 1's 047541 PKR 360.08 PKR 360.08/vial/unit No comparator
Zexate Methotrexate 25 mg/mL (50 mg total) Injection 100's 047541 PKR 16,619.27 PKR 166.19/vial/unit No comparator
A to Z

All 21 Atco Pharma International brands in Pakistan

  • Adrim Doxorubicin · 50 mg/25 mL injection
  • AgB Hepatitis B vaccine (recombinant HBsAg), HbsAg SURFACE ANTIGEN · 10 mcg/0.5 mL vaccine, 20 mcg vaccine
  • Bortezomib Bortezomib · 3.5 mg injection
  • Daxotel Docetaxel · 120 mg/6 mL injection, 160 mg/8 mL injection, 20 mg/mL infusion
  • FIVOFLU Fluorouracil (5-FU) · 250 mg/5 mL (50 mg/mL) injection, 50 mg/mL injection, 500 mg (50 mg/mL) injection
  • FYTOSID Etoposide · 100 mg injection
  • Gemita Gemcitabine · 1 g injection, 200 mg injection
  • Kemocarb Carboplatin · 150 mg/15 mL injection, 450 mg/45 mL injection
  • KEMOPLAT Cisplatin · 10 mg/20 mL injection, 50 mg/100 mL injection
  • Nanoxel Paclitaxel · 100 mg injection, 30 mg injection, 300 mg injection
  • NEUMOCORT Budesonide · 200 mcg inhalation
  • NEUMOCORT FORTE Budesonide · 400 mcg inhalation
  • NEUMOCORT FORTE METERD-DOSE INHALER Budesonide · 400 mcg inhalation
  • NEUMOCORT METERD-DOSE INHALER Budesonide · 200 mcg inhalation
  • Neutrofil Filgrastim · 48 MU/1.6 mL injection
  • Oxitan Oxaliplatin · 100 mg/20 mL (5 mg/mL) infusion, 50 mg/10 mL (5 mg/mL) infusion
  • PABAL RTS Carbetocin · 100 mcg/mL injection
  • PABAL® RTS 100 MICROGRAMS Carbetocin · 100 MCG/mL injection
  • PENTASA MESALAZINE · 1 g sachet
  • VINELBINE Vinorelbine tartrate · 10 mg injection
  • Zexate Methotrexate · 25 mg/mL (50 mg total) injection, 50 mg (25 mg/mL) injection
Questions

Atco Pharma International: common questions

How many products does Atco Pharma International have in Pakistan?

Atco Pharma International (Pvt) Ltd has 38 registered medicine presentations in Pakistan, sold under 21 brands and covering 18 generic medicines.

What are the main brands of Atco Pharma International?

By number of registered strengths and packs, its largest brands are Daxotel (Docetaxel), FIVOFLU (Fluorouracil (5-FU)), Nanoxel (Paclitaxel), AgB (Hepatitis B vaccine (recombinant HBsAg), HbsAg SURFACE ANTIGEN) and Gemita (Gemcitabine). This is not a sales ranking.

Which therapy areas does Atco Pharma International cover?

The most products are in Oncology & immunology (25), Respiratory & allergy (6), Vaccines & immunologicals (2), Reproductive & genitourinary (2) and Gastrointestinal & hepatology (2).

Where can I see Atco Pharma International medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Atco Pharma International (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 12, 2026, from https://medinfobase.com/company/atco-pharma-international-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9